utilize absorbable suspension sutures more frequently in their practice as part of an evolving tool set to maximize clinical results and patient satisfaction.
DISCLOSURES
Dr. Lorenc is a consultant for Jonhson & Johnson, Merz, Allergan, Galderma, Sinclair Pharma, CorMedix, ThermiAesthetics, and Almirall Pharma. Dr. Ablon is an Associate Clinical Professor at UCLA, consultant and advisory board member for Galderma, Sinclair, Thermi-Almirall, Erchonia, Sunetics, Nutrafol, and Lifes2Good. Dr. Few is a consultant and investigator for Allergan, Galderma, Merz, Venus Concepts, and Zeltiq. Dr. Gold is a consultant for Sinclair Pharma and Thermi-Almirall. Dr. Goldberg is a consultant for Sinclair Pharma. Dr. Mandy is a consultant for and has received salary from Almirall and Sinclair Pharma; is an advisory board member for and has received honoraria from Galderma USA and Valeant Pharmaceuticals; is an advisory board member for Merz Aesthetics; and has received honoraria from Procter & Gamble Company and from International Speaker & Faculty Education. Dr. Nestor is a consultant and advisory board member for and has received research grants from Sinclair Pharma, and is a consultant, advisory board member, and speaker for Thermi-Almirall; a consultant and advisory board member for Almirall; a consultant for Bayer Healthcare; a consultant and speaker for Sensus Healthcare; a speaker and principal investigator for IFC, S.A; a principal investigator and consultant for CROMA Pharma, Ferndale, and Johnson & Johnson; and a principal investigator for Actavis, Allergan, Annacor Pharmaceuticals, Biofrontera, Brickell Biotech, Cynova Laboratories, DUSA Pharmaceuticals, Demira, Evolus, Intraderm, LEO Pharma, MC2 Therapeutics, and SASIF & Sonoma. Dr. Weinkle is a consultant, principal investigator, advisory board member and speaker for Allergan; a stock holder and principal investigator for Derm Advance; an advisory board member, consultant, and speaker for Ethicon and Merz; a consultant and speaker for Galderma; a consultant for Proctor & Gamble; and a principal investigator for Teoxane, Alphaeon, and Sinclair Pharma.
ACKNOWLEDGMENTS
The authors thank Ginny Vachon PhD of Principal Medvantage, LLC, Atlanta, Georgia, USA for providing medical writing support, provided by X-Medica, LLC with an educational grant from Sinclair.
REFERENCES
- Farkas JP, Pessa JE, Hubbard B, Rohrich RJ. The science and theory behind facial aging. Plast Reconstr Surg Glob Open. 2013;1(1):e8-e15.
- Cotofana S, Fratila AA, Schenck TL, Redka-Swoboda W, Zilinsky I, Pavicic T. The anatomy of the aging face: a review. Facial Plast Surg. 2016;32(3):253-260.
- Kretlow JD, Hollier LH, Jr., Hatef DA. The facial aging debate of deflation versus attenuation: attenuation strikes back. Plast Reconstr Surg. 2012;130(1):180e-181e; author reply 182e.
- Wong CH, Mendelson B. Newer understanding of specific anatomic targets in the aging face as applied to injectables: aging changes in the craniofacial skeleton and facial ligaments. Plast Reconstr Surg. 2015;136(5 Suppl):44S-48S.
- Nestor MS, Ablon G, Andriessen A, et al. Expert consensus on absorbable advanced suspension technology for facial tissue repositioning and volume enhancement. J Drugs Dermatol. 2017;16(7):661-666.
- Sillhouette InstaLift™ [instructions for use]. Irvine, CA: Sillhouette Lift Inc.; August 3, 2017.
- Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915-22.
- Stein P, Vitavska O, Kind P, Hoppe W, Wieczorek H, Schurer NY. The biological basis for poly-L-lactic acid-induced augmentation. J Dermatol Sci. 2015;78(1):26-33.
- Nestor MS. Facial lift and patient satisfaction following treatment: 12-month data - a prospective, masked, controlled clinical study. Poster presented at: 2018 South Beach Symposium (SBS); March 1–4, 2018; Miami Beach, FL. Abstract 66937.
- Nestor MS. Improved patient satisfaction 12 months following treatment with Silhouette InstaLift™: data from a prospective, masked, controlled clinical study. Poster presented at: IMCAS World Congress 2018; February 1–3, 2018; Paris, France.
- Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg. 2013;39(11):1602-1612.
- Ogilvie MP, Few JW, Jr., Tomur SS, et al. Rejuvenating the face: an analysis of 100 absorbable suture suspension patients [published online December 8, 2017]. Aesthet Surg J.
- Bauer U, Graivier MH. Optimizing injectable poly-L-lactic acid administration for soft tissue augmentation: the rationale for three treatment sessions. Can J Plast Surg. 2011;19(3):e22-e27.
- Sinclair Pharma plc. Internal safety report. London, UK: December 2017.
AUTHOR CORRESPONDENCE
Z. Paul Lorenc MD FACS lorenc@lorenc.com